Related Experiment Video
Updated: Sep 30, 2025

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Reducing Cardiovascular Risk in the Medicare Million Hearts Risk Reduction Model: Insights From the National
William B Borden1, Jingyan Wang2, Philip Jones3
1George Washington University, Washington, DC (W.B.B.).
The Million Hearts initiative can significantly reduce atherosclerotic cardiovascular disease (ASCVD) risk in high-risk Medicare patients. Achieving optimal risk factor reductions in cardiology practices could lead to substantial ASCVD risk reduction and incentive payments.
Area of Science:
- Cardiology
- Public Health
- Health Economics
Background:
- The Million Hearts Cardiovascular Disease Risk Reduction Model incentivizes practices to reduce 10-year atherosclerotic cardiovascular disease (ASCVD) risk in high-risk Medicare patients (ASCVD risk ≥30%).
- This study estimates average practice-level ASCVD risk reduction by applying optimal clinical trial outcomes to a real-world, high-risk population.
Purpose of the Study:
- To estimate the potential average practice-level ASCVD risk reduction achievable within the Million Hearts Model.
- To assess the proportion of practices that could meet incentive thresholds based on modeled risk factor modifications.
Main Methods:
- Utilized observational registry data from the National Cardiovascular Data Registry (NCDR) Practice Innovation and Clinical Excellence (PICE) Registry (January 2013–June 2016).
- Modeled ASCVD risk reductions using historical clinical trial data for cholesterol (26.5%), systolic blood pressure (10.9%), and smoking cessation (21.8%).
- Calculated average ASCVD risk reduction from individual and combined risk factor modifications and determined the percentage of practices achieving Million Hearts incentive thresholds.
Main Results:
- The study population included 135,166 patients, with 16,248 (12.0%) identified as high-risk (10-year ASCVD risk ≥30%) without existing ASCVD.
- Mean 10-year ASCVD risk in the high-risk group was 41.9%.
- Combined risk factor reductions (cholesterol, blood pressure, smoking) modeled a 9.7% ± 3.6 reduction in 10-year ASCVD risk. 73.0% of practices achieved ≥10% risk reduction, and 27.0% achieved 2-10% reduction.
Conclusions:
- Approximately 1 in 8 patients in cardiology practices have high ASCVD risk (≥30%) qualifying for the Million Hearts Model.
- Targeting key modifiable risk factors and achieving clinical trial-like reductions can substantially lower ASCVD risk.
- The Million Hearts Model demonstrates significant potential benefits, and these findings offer guidance for participating practices to achieve incentive payments.
More Related Videos
Related Concept Videos
Atherosclerosis III: Management
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease V: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Heart Failure V: Medical Management

